* Ekso Bionics Holdings Inc EKSO.OQ reported a quarterly
adjusted loss of 19 cents per share for the quarter ended in
June. The lone analyst forecast for the quarter was for a loss
of 25 cents per share.
* Revenue fell 2.3% to $2.21 million from a year ago; analysts
expected $2.10 million.
* Ekso Bionics Holdings Inc's reported EPS for the quarter was a
loss of 10 cents.
* The mean earnings estimate of analysts had fallen by
about 4.2% in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Ekso Bionics Holdings Inc shares had fallen by 11.5% this
quarter and lost 20.6% so far this year.
* The company reported a quarterly loss of $1.27 million.
* Wall Street's median 12-month price target for Ekso Bionics
Holdings Inc is $10.00
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated July 29 at 09:48 p.m. All
figures in US dollars unless otherwise stated